Vaccines
Site Locations
At IQVIA Laboratories Vaccines, we built a state-of-the-art CRO, driven by scientific discipline, and aided by our advanced facilities and cutting-edge technology through our global network of specialty laboratories. With a combined 30 years of industry expertise, we were well-positioned to become the leading specialty lab for what’s next in therapeutic testing and development.
We have continued to add to our portfolio of services, bench of scientific experts, and global laboratory footprint. We’ve also formed a strategic partnership with the UK Health Security Agency ensuring that we deliver the diverse testing needed to our global sponsors.
Our global network of laboratories serves as an extension of your own scientific teams to scale, quickly and efficiently to meet demands for specialty testing for all phases of development.
Learn more about our vaccines facilities:
- Laval, Canada
- Marburg, Germany
- Durham NC, USA
- Beijing, China
State-of-the-Art Facilities
Our state-of-the-art facility design promotes scientific excellence through our team of scientists, highly automated workflows, and data management through Laboratory Information Management System (LIMS) systems to support client studies whether they are research based or require fully validated systems as per required standards, including 21 CFR Part 11 compliance. Documentation is preserved in internal and external archives with restricted access to safeguard data and study materials throughout the retention period.
Quality Management System
Our well-defined quality management system (QMS) seamlessly aligns with regulatory requirements GCLP and GCP standards ensure compliance for our clients and for the studies we support.
Current Accreditations/Certifications
- GCLP (Vaccines)
- GLP (Beijing)
- AAALAC — Association for Assessment and Accreditation of Laboratory Animal Care (Preclinical Laval and Beijing)
- CCAC — Canadian Council on Animal Care (Preclinical)
- OLAW — Office of Laboratory Animal Welfare (Preclinical)
- BBL — Belgian Banking License (Gosselies)
Robust Data and Scientific Processes
We support your preclinical and clinical molecule/vaccine candidate development — with data and study sample testing managed by our validated, customized, LIMS and its full audit trail.
Sample Management
Our team provides the same uncompromising attention to detail whether you have few samples or a million. Each analytical and data plan is custom crafted to ensure we meet all deliverables for all stakeholders. Customized reporting delivers the specific data results you want, on the schedule you require.
Integrated Approach
IQVIA Laboratories Vaccines global scale and high-volume capabilities combines our high-touch, individualized service with the capacity and global coverage to move even the largest projects forward on time and on budget. All while adhering to regulatory requirements including chain of custody, IATA (International Air Transport Association) shipping guidelines, and sample verification upon receipt. We also provide both long- and short-term sample storage. Our fully integrated approach streamlines the management and handling of your data throughout the sample life cycle, resulting in accurate, actionable, and timely evidence.
Explore more
- Assay Catalog
- Assay Development and Technology Transfer
- Early Development Assays
- High Throughput Testing
- Immunotherapy
- Preclinical Assay Development and In Vivo Services
- Translational Sciences
- Scientists and Experts
- Infectious Disease
- Leading the Way to Develop Reference Assays for COVID-19 Vaccines
- Assays for Vaccine Development and Testing